RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
-8.24%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.44B
AUM Growth
+$3.44B
Cap. Flow
+$132M
Cap. Flow %
3.85%
Top 10 Hldgs %
35%
Holding
142
New
7
Increased
68
Reduced
12
Closed
10

Top Buys

1
ALGN icon
Align Technology
ALGN
$32.7M
2
HUM icon
Humana
HUM
$27M
3
XLV icon
Health Care Select Sector SPDR Fund
XLV
$25.6M
4
PEN icon
Penumbra
PEN
$24.5M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$20.5M

Top Sells

1
HCA icon
HCA Healthcare
HCA
$94M
2
EHC icon
Encompass Health
EHC
$35.7M
3
IRTC icon
iRhythm Technologies
IRTC
$17.9M
4
XENT
Intersect ENT, Inc
XENT
$15.4M
5
RIGL icon
Rigel Pharmaceuticals
RIGL
$14.7M

Sector Composition

1 Healthcare 96.7%
2 Consumer Staples 0.96%
3 Industrials 0.47%
4 Financials 0.15%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GMDA
101
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$3.85M 0.11%
2,175,000
+20,700
+1% +$36.6K
PRTK
102
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.35M 0.1%
1,734,037
+7,400
+0.4% +$14.3K
BLSA
103
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$3.06M 0.09%
309,000
– –
OKUR
104
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
$3.03M 0.09%
1,143,185
– –
SPRB
105
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$2.82M 0.08%
1,622,689
– –
MGNX icon
106
MacroGenics
MGNX
$121M
$2.82M 0.08%
954,728
+22,000
+2% +$64.9K
FATE icon
107
Fate Therapeutics
FATE
$115M
$2.73M 0.08%
110,000
– –
THRX
108
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$2.42M 0.07%
437,329
– –
CGEN icon
109
Compugen
CGEN
$133M
$2.39M 0.07%
1,289,990
– –
JYAC
110
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$2.04M 0.06%
206,200
– –
FUSN
111
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$2.02M 0.06%
809,854
-138,473
-15% -$345K
PRLD icon
112
Prelude Therapeutics
PRLD
$69.1M
$1.93M 0.06%
368,959
– –
FULC icon
113
Fulcrum Therapeutics
FULC
$353M
$1.88M 0.05%
384,590
-50,000
-12% -$245K
TPST icon
114
Tempest Therapeutics
TPST
$46.6M
$1.77M 0.05%
823,654
– –
PHAS
115
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$1.67M 0.05%
2,774,869
+161,044
+6% +$96.6K
EPIX icon
116
ESSA Pharma
EPIX
$11.2M
$1.65M 0.05%
524,944
– –
SYRE icon
117
Spyre Therapeutics
SYRE
$1.02B
$1.55M 0.05%
3,072,034
+1,260,609
+70% +$637K
TLPH icon
118
Talphera
TLPH
$11.2M
$1.55M 0.05%
6,329,202
– –
VIGL
119
DELISTED
Vigil Neuroscience
VIGL
$1.22M 0.04%
471,958
– –
VINC
120
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$1.08M 0.03%
814,194
– –
ELVN icon
121
Enliven Therapeutics
ELVN
$1.24B
$1.03M 0.03%
842,402
– –
BCEL
122
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$828K 0.02%
462,530
– –
APLT icon
123
Applied Therapeutics
APLT
$73.7M
$665K 0.02%
701,680
– –
SPRO icon
124
Spero Therapeutics
SPRO
$117M
$571K 0.02%
770,710
-220,203
-22% -$163K
NUVB.WS icon
125
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$38K ﹤0.01%
134,028
– –
2 3 4
5
6